Prevalence of obesity and hyperinsulinemia: Its association with lipid profile in healthy individuals from Maracaibo, Venezuela;Prevalencia de obesidad e hiperinsulinemia en una población aparentemente sana de Maracaibo, Venezuela y su relación con las concentraciones de lípidos y lipoproteínas del suero

Investigacion Clinica

Volumn 44, Issue 1, 2003, Pages 5-19

  Campos, Gilberto ^a   Ryder, Elena ^a   Diez Ewald, María ^a   Rivero, Francisco ^b   Fernández, Virginia ^a   Raleigh, Xiomara ^a   Arocha Piñango, Carmen Luisa ^c  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

^b PDVSA INTEVEP   (Venezuela)

^c INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

Author keywords

BMI; Hyperinsulinemia; Lipid profile; Obesity

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; HUMAN; HYPERINSULINEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; VENEZUELA;

ADULT; AGED; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; HYPERINSULINISM; INSULIN; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; OBESITY; PREVALENCE; TRIGLYCERIDES; VENEZUELA;

EID: 0345269222     PISSN: 05355133     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Sex, age, cardiovascular risk factors, and coronary heart disease. A prospective follow-up study of 14786 middle-age men and women in Finland. Circulation 1999; 99:1165-1172.
2. Hubert HB, Feinleib M, Macnamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67:968-977.
3. Fava-Lamon S, Wilson PWF, Schaefer EJ. Impact of body mass index on coronary heart disease risk factor in men and women. The Framingham offspring study. Arterioscler Thromb Vasc Biol 1996; 16:1509-1515.
4. Manson JE, Colditz GA, Stampfer MJ, Willet W, Rosner B, Monson RR, Speizer FE, Hennekens CH. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 1990; 322:882-889.
5. Jousilahti P, Tuomilehto J, Vartiainen E, Pekkanen J, Puska P. Body weight, cardiovascular risk factors, and coronary mortality. 15-year follow-up of middle-age men and women in Eastern Finland. Circulation 1996; 93:1372-1379.
6. Ravussin E. Energy metabolism in obesity. Studies in Pima Indians. Diabetes Care 1993; 6(Supl. 1):232-238.
7. Ravussin E, Valencia ME, Esparza J, Bennett PH, Schulz LO. Effects of a traditional lifstyle on obesity in Pima Indians. Diabetes Care 1994; 17(9):1067-1074.
8. Perez BF, Carrasco PE, Santos MJL, Calvillan CM, Albala BC. Prevalencia de obesidad, hipertensión y dislipidemia en grupos aborígenes rurales de Chile. Rev med. Chile 1999; 127(10):1-10.
9. Reaven MG. Role of insulin resistance in human disease. Diabetes 1988; 37:1595-1607.
10. Ronnemaa T, Laakso M, Pyorala K, Kalio V, Puukka P. High fasting plasma insulin is an indicator of coronary heart disease in non-insulin dependent diabetic patients and nondiabetic subjects. Arterioscler Thromb 1991; 11:80-90.
11. Chen IYD, Reaven GM. Insulin resistance and atherosclerosis. Diabetes Reviews 1997; 5(4):105-116.
12. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais G, Moorjani S, Lupien PJ. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996; 334:952-957.
13. Ruige JB, Assendelft JJ, Dekker JM, Kostense PJ, Heine RJ, Bouter LM. Insulin and risk of cardiovascular disease. A meta analysis. Circulation 1998; 97:996-1001.
14. Pyorala M, Miettinen H, Laakso M, Pyorala K. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-age men. The 22-year follow-up results of Helsinki Policemen Study. Circulation 1998; 98:398-404.
15. Garg A. Insulin resistance in the pathogenesis of dyslipidemia. Diabetes Care 1996; 19(4):387-389.
16. Mykkanen L, Kuusisto J, Haffner SM, Pyorala K, Laakso M. Hyperinsulinemia predicts multiple atherogenic changes in lipoproteins in elderly subjects. Arterioseler Thromb 1994; 14:518-526.
17. Barakat H, Carpenter JW, Mclendon VD, Khazane P, Leggett N, Heath J, Marks R. Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition. Possible link between hyperinsulinemia and atherosclerosis. Diabetes 1990; 39:1527-1533.
18. Haffner SM, González C, Miettinen H, Howard BV, Stern MP. LDL size and subclases pattern in Mexico city residents and San Antonio Mexican Americans. Arterioseler Thromb Vase Biol 1995; 15:2131-2141.
19. Selby JV, Austin MA, Newman B, Zhang D, Quesenberry CP, Mayer EJ, Krauss RM. LDL subclass phenotypes and insulin resistance syndrome in women. Circulation 1993; 88:381-387.
20. Johansson J, Carlson LA, Landaou C, Hamsten A. High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients. Arterioscler Thromb 1991; 11:174-182.
21. Eckardstein AV, Nofer J-R, Assmann G. High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and cholesterol transport. Arterioseler Thromb Vasc Biol 2001; 21(1):13-43.
22. Friedewald WT, Levy R, Fredrickson DS. Estimation of serum low density lipoprotein without the use of a preparative ultra-centrifuge. Clin Chem 1972; 18:499-502.
23. Camejo G, Cortez M, Mosquera B.: Photometric measurement of lipoprotein-cholesterol after agarose electroforesis. Comparison with simple spin ultracentrifugal analysis. Clin Chim Acta 1981; 11:239-245.
24. Consenso Venezolano de Lípidos. International Lipid Information Bureau. Capítulo Venezuela. Park Davis, 2000. pp 1-39.
25. , ILIB Latinoamériea. Recomendaciones de ILIB para el diagnóstico de las dislipidemias en Latinoamérica. Avances Cardiológicos 1994; 14(Sup.1):6-22.
26. García-Araujo M, Semprún-Fereira M, Sulbaran TA, Silva E, Calmon G. Factores nutricionales y metabólicos como riesgo de enfermedades cardiovasculares en una población adulta de Marcaibo, Estado Zulia, Venezuela. Invest Clin 2001; 42(1):23-42.
27. Hoffmann I, Jimenez E, Roa M, Palermo C, Baldonedo R, Cubeddu R, Cubeddu L. Incidencia de factores de riesgo cardiovascular en una población de sujetos venezolanos sanos. Arch Venez Farmacol Terapéu 2001; 20 (supl. 1):S10-S14.
28. Nichaman MZ, Garcia G. Obesity in Hipanic Americans. Diabetes Care 1991; 14(7):691-694.
29. Fernández V, Campos G, Rincón E, Valbuena H, Ryder E, Gómez ME, Raleigh X. Diferencias cualitativas y cuantitativas en las lipoproteínas del plasma entre hombres y mujeres obesos hiperlipidémicos o normolipidémicos. Invest Clin 1996; 37(1): 17-34.
30. Florez H, Valbuena H, Ryder E, Rincón E, Campos G, Castillo S, González J, Fernández V, Raleigh X, Gómez ME. Dislipidemias e hiperinsulinemia en familiares normoglicémicos-obesos de pacientes con diabetes mellitus no insulino dependiente. Invest Clín 1995; 36(3):131-148.
31. Bosch RV, Rodríguez M, Geron N. Características de las dislipoproteinemias más frecuentes en Venezuela estudiadas mediante un análisis de ultracentrifugación preparativa. Invest Clín 1987; 28(1):5-19.